SLC46A2 and neoplasm: Mainly, survival analyses showed that the same expression of SLC46A2, ZNF367, AC107214.1 and NCBP1 genes in the primary and LNM lesions can provides more potent prognostic information when no analyses of the primary tumor have been done.